Stereotactic Body Radiation Therapy (SBRT) Clinical Trials
21 recruitingRadiation
Phase 212Not Applicable8Phase 11Phase 31
Showing 1–20 of 21 trials
Recruiting
Phase 2Phase 3
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Hepatocellular Carcinoma (HCC)
Tuen Mun Hospital106 enrolled1 locationNCT07293468
Recruiting
Phase 2
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
National Cancer Institute (NCI)65 enrolled1 locationNCT05361798
Recruiting
Not Applicable
Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto52 enrolled1 locationNCT07112170
Recruiting
Not Applicable
SBRT in HCC With Oligoprogression on First-line Immunotherapy
HCC
Chinese University of Hong Kong30 enrolled1 locationNCT06434480
Recruiting
Phase 1
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
OsteosarcomaPulmonary Recurrence of Osteosarcoma
Emory University12 enrolled1 locationNCT06492954
Recruiting
Phase 2
Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
Prostate CA
British Columbia Cancer Agency100 enrolled1 locationNCT06835725
Recruiting
Phase 2
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Mucosal Melanoma
Memorial Sloan Kettering Cancer Center20 enrolled2 locationsNCT05384496
Recruiting
Not Applicable
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
Breast CarcinomaMetastatic Breast CancerAnatomic Stage IV Breast Cancer AJCC v8
Mayo Clinic45 enrolled2 locationsNCT06055881
Recruiting
Phase 2
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Prostate Cancer
Weill Medical College of Cornell University50 enrolled1 locationNCT04402151
Recruiting
Phase 2
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University20 enrolled1 locationNCT07297004
Recruiting
Phase 2
Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
OligoProgressive Metastatic DiseaseCastrate Resistance Prostate Cancer
University Health Network, Toronto75 enrolled1 locationNCT06927635
Recruiting
Not Applicable
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
Intraprostatic Prostate Cancer
NYU Langone Health28 enrolled1 locationNCT07142967
Recruiting
Not Applicable
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
Non-metastasized Unresectable Pancreatic Carcinoma
Cancer Research Antwerp160 enrolled9 locationsNCT06691425
Recruiting
Phase 2
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Breast Cancer
Xijing Hospital27 enrolled2 locationsNCT06914440
Recruiting
Not Applicable
Single Fractions SBRT for Prostate Cancer
Prostate Cancer
Fabio Cury12 enrolled1 locationNCT04004312
Recruiting
Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
Prostate Cancer
Memorial Sloan Kettering Cancer Center215 enrolled7 locationsNCT05169970
Recruiting
Not Applicable
Cardiac Radioablation for VT
Myocardial InfarctionVentricular Tachycardia
Corewell Health East24 enrolled1 locationNCT06593418
Recruiting
Phase 2
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University31 enrolled1 locationNCT06767007
Recruiting
Phase 2
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Primary Liver Cancer
Tianjin Medical University Cancer Institute and Hospital130 enrolled1 locationNCT06766643
Recruiting
Phase 2
Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
HR-positive,HER2-negative Breast Cancer
First Affiliated Hospital of Zhejiang University30 enrolled1 locationNCT06705127